Everads Injector
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Everads Injector, covering 2025-05-31 to 2025-05-31. Get the full timeline:
Most recent: Clinical Trial Update: Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME [NA]